Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
Journal of Applied Gerontology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Rinck, C.
Right arrow Articles by Calkins, C. F.
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Patterns of Psychotropic Medication Use Among Older Persons with Developmental Disabilities

Christine Rinck

University of Missouri, Kansas City Institute for Human Development

Carl F. Calkins

University of Missouri, Kansas City Institute for Human Development

While the prevalence of psychotropic drug use among older persons has been widely investigated, use of these agents in older persons with developmental disabilities has received little attention. We found this latter group to be prescribed more polypharmacy, antipsychotic, and antianxiety agents than were younger peers. Those who lived in more restricted residential settings (e.g., in skilled nursing facihties or in rural areas) had higher prevalence rates of antipsychotic drug use. In light of these findings, implications for policymakers are described. Measures to ensure the appropriateness of the prescription should be established. Better monitoring of polypharmacy and drug side effects should be initiated. Active programming should continue throughout the lifespan and training should be conducted for service providers.

Journal of Applied Gerontology, Vol. 8, No. 2, 216-227 (1989)
DOI: 10.1177/073346488900800208


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?